News Alert

Ranking GOP Senator on Key Committee Opens Investigation into 340B Hospital Revenue

Bill Cassidy
Sen. Bill Cassidy, ranking Republican on the Senate HELP Committee, does not appear to have the authority to compel hospitals to respond to his inquiry on 340B revenue.
The top Republican on an influential Senate committee has opened an investigation into how two major health systems use revenue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Looming Government Shutdown Poses 340B Program Uncertainty, Potential Legal Proceeding Slowdown

US Capitol
Congress is unlikely to pass a 340B program overhaul in 2024 unless there is unexpected pressure from appellate court decisions or a Senate "group of 6" breakthrough, attorneys and lobbyists said.
The government agency that oversees the 340B program will retain just over half of its staff in the event of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Shutdown Looms, Momentum Slows on Bills with Key 340B Changes

Rep. Harshbarger (R-Tenn.) co-sponsored a PBM transparency bill with a 340B provision, but there had not been any floor or committee votes scheduled on the legislation.
As the country moves closer to a federal government shutdown, movement on two bipartisan House bills with 340B program language, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly and Novo Post 340B Refund Notices, Amgen Posts 340B Replenishment Notice

Eli Lily and Novo Nordisk
Lilly and Novo Nordisk are refunding 340B covered entities on some products due to 340B ceiling price adjustments.
Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health, Researchers Spar over Biosimilar Study

Maureen Testoni headshot
Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.
Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Transparency, Patient Assistance Requirements Needed in 340B, Say Drugmaker-Backed Groups

Justin Leventhal
Justin Leventhal, a senior policy analyst for the American Consumer Institute, has advocated for more 340B transparency alongside other drugmaker-backed groups.
Amid ongoing congressional legislative proposals to boost transparency and other requirements for 340B hospitals, two advocacy groups that receive drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Could the States Resolve the Contract Pharmacy Impasse?

340B Report Publisher and CEO Ted Slafsky addresses enforcement actions and litigation surrounding state 340B contract pharmacy laws in his latest column.
After a recent lull in the ongoing battle over whether drug manufacturers can continue to place restrictions on access to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report